Log In
Print
BCIQ
Print
Print this Print this
 

lixivaptan (CRTX 080)

Also known as: formerly VPA-985

  Manage Alerts
Collapse Summary General Information
Company Cornerstone Therapeutics Inc.
DescriptionSelective vasopressin V2 receptor antagonist
Molecular Target Vasopressin 2 (V2) receptor
Mechanism of ActionVasopressin 2 (V2) receptor antagonist
Latest Stage of DevelopmentRegistration
IndicationHyponatremia
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today